1-5 of 5
Michele Carbone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Expression of Concern: HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients

Andrea Napolitano, Daniel J. Antoine, Laura Pellegrini, Francine Baumann, Ian Pagano, Sandra Pastorino, Chandra M. Goparaju, Kirill Prokrym, Claudia Canino, Harvey I. Pass, Michele Carbone, Haining Yang
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (6): 1529.
https://doi.org/10.1158/1078-0432.CCR-20-0338
Published: 13 March 2020
View article titled, Expression of Concern: HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients
Open the PDF for Expression of Concern: HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients in another window
Journal Articles

HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients

Andrea Napolitano, Daniel J. Antoine, Laura Pellegrini, Francine Baumann, Ian Pagano, Sandra Pastorino, Chandra M. Goparaju, Kirill Prokrym, Claudia Canino, Harvey I. Pass, Michele Carbone, Haining Yang
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (12): 3087–3096.
https://doi.org/10.1158/1078-0432.CCR-15-1130
Published: 14 June 2016
View article titled, HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients
Open the PDF for HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients in another window
Includes: Supplementary data
Journal Articles

CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma

Zeyana Rivera, Soldano Ferrone, Xinhui Wang, Sandro Jube, Haining Yang, Harvey I. Pass, Shreya Kanodia, Giovanni Gaudino, Michele Carbone
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5352–5363.
https://doi.org/10.1158/1078-0432.CCR-12-0628
Published: 30 September 2012
View article titled, CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma
Open the PDF for CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma in another window
Includes: Supplementary data
Journal Articles

Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma

Michele Carbone, Haining Yang
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3): 598–604.
https://doi.org/10.1158/1078-0432.CCR-11-2259
Published: 31 January 2012
View article titled, Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma
Open the PDF for Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma in another window
Journal Articles

Gene Expression Profiles Predict Survival and Progression of Pleural Mesothelioma

Harvey I. Pass, Zhandong Liu, Anil Wali, Raphael Bueno, Susan Land, Daniel Lott, Fauzia Siddiq, Fulvio Lonardo, Michele Carbone, Sorin Draghici
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (3): 849–859.
https://doi.org/10.1158/1078-0432.CCR-0607-3
Published: 10 February 2004
View article titled, Gene Expression Profiles Predict Survival and Progression of Pleural Mesothelioma
Open the PDF for Gene Expression Profiles Predict Survival and Progression of Pleural Mesothelioma in another window